20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Medpace Holdings Inc (MEDP) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Cincinnati, United States with about 6,500 employees. Its market capitalization is roughly $17 billion. In the fiscal year ended 2025-12-31, MEDP reported $2.5B in revenue and $451M in net income.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
Interactive charts & full statements → Open the MEDP valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.8B | $2.5B | $2.1B | $1.9B | $1.5B | $1.1B | $926M | $861M | $705M | $436M | $422M | $359M | $290M | $273M |
| Gross Profit | $800M | $761M | $656M | $525M | $432M | $328M | $279M | $246M | $216M | $175M | $172M | $156M | $134M | $124M |
| Gross Margin % | 28.8% | 30.1% | 31.1% | 27.8% | 29.6% | 28.7% | 30.1% | 28.5% | 30.6% | 40.1% | 40.8% | 43.6% | 46.1% | 45.6% |
| Operating Income (EBIT) | $583M | $535M | $447M | $337M | $279M | $199M | $167M | $127M | $101M | $65M | $52M | $21M | $26M | $59M |
| Operating Margin % | 21.0% | 21.1% | 21.2% | 17.9% | 19.1% | 17.4% | 18.0% | 14.8% | 14.3% | 14.9% | 12.4% | 5.7% | 9.0% | 21.6% |
| Net Income | $492M | $451M | $404M | $283M | $245M | $182M | $145M | $100M | $73M | $39M | $13M | ($9M) | ($16M) | $25M |
| Net Margin % | 17.7% | 17.8% | 19.2% | 15.0% | 16.8% | 15.9% | 15.7% | 11.7% | 10.4% | 9.0% | 3.2% | -2.4% | -5.4% | 9.1% |
| EBITDA | $613M | $571M | $505M | $362M | $308M | $223M | $187M | $150M | $140M | $111M | $99M | $89M | $94M | $88M |
| Earnings Per Share (EPS) | $16.90 | $15.28 | $12.63 | $8.88 | $7.29 | $4.82 | $3.86 | $2.67 | $1.98 | $0.98 | $0.37 | $-0.22 | $-0.53 | $0.65 |
| Shares Outstanding (M) | 29M | 30M | 32M | 32M | 34M | 38M | 38M | 38M | 37M | 40M | 36M | 40M | 29M | 38M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $707M | $707M | $708M | $660M | $603M | $559M | $537M | $533M |
| Gross Profit | $202M | $196M | $205M | $197M | $180M | $178M | $178M | $169M |
| Gross Margin % | 28.5% | 27.8% | 29.0% | 29.8% | 29.8% | 31.9% | 33.2% | 31.7% |
| Operating Income (EBIT) | $147M | $142M | $153M | $142M | $126M | $114M | $125M | $112M |
| Operating Margin % | 20.8% | 20.0% | 21.6% | 21.5% | 20.9% | 20.3% | 23.4% | 21.1% |
| Net Income | $121M | $124M | $135M | $111M | $90M | $115M | $117M | $96M |
| Net Margin % | 17.2% | 17.5% | 19.1% | 16.8% | 15.0% | 20.5% | 21.8% | 18.1% |
| EBITDA | $145M | $154M | $164M | $150M | $132M | $125M | $141M | $126M |
| Earnings Per Share (EPS) | $4.22 | $4.28 | $4.67 | $3.74 | $2.99 | $3.67 | $3.66 | $3.01 |
| Shares Outstanding (M) | 29M | 29M | 29M | 30M | 30M | 31M | 32M | 32M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $753M | $713M | $609M | $433M | $388M | $263M | $259M | $202M | $157M | $97M | $92M | $86M | $75M | $98M |
| Capital Expenditures (CapEx) | $34M | $31M | $37M | $37M | $37M | $28M | $31M | $18M | $16M | $12M | $14M | $6M | $5M | $5M |
| Free Cash Flow (FCF) | $718M | $682M | $572M | $397M | $351M | $235M | $227M | $184M | $141M | $85M | $78M | $79M | $70M | $94M |
| FCF Margin % | 25.8% | 27.0% | 27.1% | 21.0% | 24.1% | 20.6% | 24.6% | 21.4% | 20.0% | 19.5% | 18.6% | 22.1% | 24.1% | 34.3% |
| Dividends Paid | — | — | — | $11M | $22M | — | — | — | — | $0M | $0M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $162M | $152M | $193M | $246M | $149M | $126M | $191M | $149M |
| Capital Expenditures (CapEx) | $7M | $7M | $5M | $16M | $6M | $10M | $8M | $11M |
| Free Cash Flow (FCF) | $155M | $145M | $188M | $230M | $142M | $116M | $183M | $139M |
| FCF Margin % | 21.9% | 20.5% | 26.6% | 34.9% | 23.6% | 20.7% | 34.1% | 26.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1B | $2.0B | $2.1B | $1.7B | $1.4B | $1.7B | $1.4B | $1.1B | $968M | $951M | $979M | $984M | $1.1B |
| Cash & Cash Equivalents | $503M | $497M | $669M | $245M | $28M | $461M | $278M | $132M | $23M | $26M | $37M | $15M | $54M |
| Total Liabilities | $1.6B | $1.5B | $1.3B | $1.1B | $966M | $707M | $585M | $417M | $378M | $447M | $368M | $571M | $695M |
| Total Debt (Short + Long-Term) | $0M | $23M | $23M | $293M | $50M | $159M | $134M | $109M | $167M | $222M | $164M | $428M | $512M |
| Total Shareholders' Equity | $434M | $459M | $826M | $559M | $386M | $953M | $806M | $726M | $590M | $504M | $611M | $413M | $402M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MEDP viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms